SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy Laboratories Ltd and Nippon Chemiphar (NC) has announced the dissolution of their joint venture Nihon Pharmaceutical Industry Co Ltd (NPI) in Japan. This follows an agreement between the two companies that allows NC to purchase the entire shareholding of its erstwhile partner. Both companies held equal shares in the venture.

 

Following the transaction, NPI will become a wholly owned subsidiary of Nippon Chemiphar. Ranbaxy sold seven generic products through the joint venture in Japan. While these products will continue to be sold through NPI, it may be transitioned to Daiichi Sankyo in the long term.

crackcrack
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×